Determinants of shingles vaccine acceptance in the United Kingdom [PDF]
PLoS ONE, 2019 BackgroundThe United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013-2014). That year, vaccination coverage ranged from 50 to 64% across the UK, but uptake has declined ever since.
Hélène Bricout +2 more
exaly +3 more sources
Zoster vaccine live for the prevention of shingles in the elderly patient
Clinical Interventions in Aging, 2008 Jamie Zussman, Lorraine YoungDepartment of Medicine, Dermatology Division, David Geffen School of Medicine at the University of California, Los Angeles, CaliforniaAbstract: Shingles, also known as herpes zoster, is a common disease in the elderly ...
Jamie Zussman
exaly +3 more sources
Shingles Vaccine Uptake Among Older Adults: Identifying Early, Later, and Nonadopters
AJPM Focus, 2023 Introduction: There is growing interest in accelerating adoptions of vaccines. This study examined factors that differentiate the acceptance and timing of uptake of the first shingles vaccine, Zostavax, among older adults in the U.S.
Jung Ki Kim +2 more
exaly +3 more sources
Risk of Shingles in Adults with Primary Sjogren’s Syndrome and Treatments: A Nationwide Population-Based Cohort Study [PDF]
PLoS ONE, 2015 Primary Sjögren's syndrome (pSS) is associated with immunological dysfunctions--a well-known risk factor of shingles. This study aimed to examine the incidence and risk of shingles in adults with pSS and pharmacological treatments.This retrospective ...
Jen-Yin Chen +2 more
exaly +2 more sources
Towards personalized vaccine repurposing for Alzheimer’s prevention: genotype-specific protective association of the shingles vaccine with odds of Alzheimer’s disease in participants of two large cohort studies [PDF]
BMC NeurologyBackground Our earlier study found that adult vaccination against shingles (herpes zoster infection caused by the reactivation of the varicella-zoster virus) was associated with significantly reduced risk of Alzheimer's disease (AD) later in life.
Hongzhe Duan +7 more
doaj +2 more sources
Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections [PDF]
npj VaccinesAS01-adjuvanted shingles (herpes zoster) vaccination is associated with a lower risk of dementia, but the underlying mechanisms are unclear. In propensity-score matched cohort studies with 436,788 individuals, both the AS01-adjuvanted shingles and ...
Maxime Taquet +2 more
doaj +2 more sources
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Respiratory Research, 2023 Plain Language Summary What is the context? After experiencing chickenpox, the varicella-zoster virus remains in the body and can be reactivated years later in a form called herpes zoster, more commonly known as shingles. Although shingles is more common
Ekaterina Safonova +3 more
doaj +1 more source
BMC Medicine, 2022 Background Varicella zoster virus (VZV) is one of the eight known human herpesviruses. Initial VZV infection results in chickenpox, while viral reactivation following a period of latency manifests as shingles.
Kevin M Bakker +3 more
doaj +1 more source
INNOVATIONS in Pharmacy, 2022 Background: Cost and lack of knowledge are key barriers to improving shingles vaccination rates in community pharmacies. A health literacy (HL) tailored infograph intervention addressing these barriers can enhance consumer interest in shingles ...
Radhika Devraj +2 more
doaj +1 more source